AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
APTARGROUP, INC. (ATR) reported that its Board of Directors increased in size from 10 to 11 members and appointed Gael Touya as a director, effective September 1, 2026. Touya will serve until the company’s 2028 annual meeting of stockholders and until his successor is elected and qualified. He is not expected to serve on any Board committee. Touya, who became President and Chief Executive Officer on September 1, 2026, has no disclosed family relationships with directors or executive officers and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K. As an employee, he will not receive additional compensation for his Board service; his CEO compensation was disclosed in an earlier Form 8-K.
APTARGROUP, INC. (ATR) reported that executive Gael Touya, Segment President and CEO Designate, sold a total of 3,740 shares of common stock on 2026-08-27 in open-market transactions. The sales occurred at weighted average prices of $133.69 and $134.55, each executed through multiple trades within stated price ranges.
APTARGROUP, INC. (ATR) received a notice that officer Gael Touya intends to sell up to 3,740 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares are valued at approximately $500,276.24, and the notice references trading on the NYSE with an anticipated date of August 27, 2026.
The notice also lists prior issuances of common stock to Touya from the issuer as restricted stock vesting under a registered plan in 2023, including grants of 129, 534, 453, and 2,624 shares for services rendered.
Morgan Stanley filed an amended Schedule 13G (Amendment No. 11) reporting beneficial ownership of AptarGroup, Inc. common stock. The filing states that Morgan Stanley and certain of its reporting units beneficially own or may be deemed to beneficially own 3,232,550 shares of AptarGroup common stock, representing 5.1% of the class as of June 30, 2026.
The filing reports 0 shares with sole voting and sole dispositive power, 2,870,214 shares with shared voting power, and 3,123,157 shares with shared dispositive power. Morgan Stanley is organized in Delaware, and the filing notes that it reflects only the securities held by specified Morgan Stanley reporting units, with other units potentially reported separately under SEC Release No. 34-39538.
Marc Prieur, Segment President of AptarGroup, sold a total of 3,500 shares of Common Stock on August 4, 2026 in two open-market transactions. One block of 3,376 shares was sold at a weighted average price of $136.2253 and another 124 shares at $137.0987.
Each reported price is a weighted average reflecting multiple trades, with individual prices ranging from $135.9000 to $136.8742 for the larger block and from $137.0908 to $137.1073 for the smaller block, as described in the transaction footnotes.
AptarGroup, Inc. President and CEO Stephan B. Tanda exercised stock options covering 9,838 shares at an exercise price of $74.79 per share and on August 3, 2026 sold 9,838 common shares at a weighted average $136.1647 (range $136.00–$136.52). He continues to hold 3,150 shares indirectly through a 401(k) trust.
Aptargroup, Inc. has a filing from shareholder Marc Prieur indicating an intention to sell up to 3,500 common shares of Aptargroup held through UBS Switzerland AG, listed on the NYSE. The proposed sale is tied to equity awards granted as RSUs and PSUs on March 14, 2022.
The disclosure also notes that 5,000 common shares of Aptargroup were sold on June 9, 2026 for approximately $577,894.00. The planned 3,500-share sale is shown with an approximate value of $476,000.00.
APTARGROUP, INC. Segment President Hedi Tlili sold 8,854 shares of Common Stock on August 3, 2026 at $135.00 per share in an open market or private transaction. Following this sale, he directly owns 15,379 shares. The trade was not made under a Rule 10b5-1 plan.
ATR has a selling security holder planning to dispose of up to 8,855 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NYSE and a proposed sale date of 08/03/2026. The shares come from restricted stock that vested under a registered plan in connection with services rendered. Vesting events include 3,604 shares on 05/02/2025, 3,598 shares on 05/01/2026, and several smaller grants on dates in 2025 and 2026.